Troester, Melissa A
Hoadley, Katherine A
D’Arcy, Monica
Cherniack, Andrew D
Stewart, Chip
Koboldt, Daniel C
Robertson, A Gordon
Mahurkar, Swapna
Shen, Hui
Wilkerson, Matthew D
Sandhu, Rupninder
Johnson, Nicole B
Allison, Kimberly H
Beck, Andrew H
Yau, Christina
Bowen, Jay
Sheth, Margi
Hwang, E Shelley
Perou, Charles M
Laird, Peter W
Ding, Li
Benz, Christopher C
Article History
Received: 23 June 2015
Revised: 4 January 2016
Accepted: 18 February 2016
First Online: 4 May 2016
Competing interests
: All authors declare no competing financial interests, except C.M.P. holds a patent applying the PAM50 algorithm; this algorithm was used to subtype the breast cancer specimens in the current work. C.M.P. is an equity stock holder, and Board of Director Member, of BioClassifier L.L.C. and GeneCentric Diagnostics.